Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

69.25 +2.02 (+3.00%)
Delayed Quote Updated: 10:09 AM EST, Nov 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Establishment Labs Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Establishment Labs® Reports Third Quarter 2026 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
News Provided by USA News Group on behalf of Conexeu Sciences Inc. 
From USA News Group
Via GlobeNewswire
News headline image
Establishment Labs® Reports Second Quarter 2026 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
From Biotech Insider
Via GlobeNewswire
News headline image
Establishment Labs® Appoints Taylor Harris to Board of Directors
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
From Biotech Insider
Via GlobeNewswire
News headline image
Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Issued on behalf of Conexeu Sciences Inc. 
From Biotech Insider
Via GlobeNewswire
News headline image
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
From Energy Metal News
Via GlobeNewswire
News headline image
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer
From Route 92 Medical, Inc.
Via GlobeNewswire
News headline image
Establishment Labs Reports First Quarter 2026 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® Refinances Credit Facility
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Leadership Transition to Support Next Phase of Growth
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Present at Jefferies London Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Reports Third Quarter 2025 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
From Establishment Labs Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.